WO2009013405A8 - Human male fertility control using spata 16 - Google Patents
Human male fertility control using spata 16 Download PDFInfo
- Publication number
- WO2009013405A8 WO2009013405A8 PCT/FR2008/000858 FR2008000858W WO2009013405A8 WO 2009013405 A8 WO2009013405 A8 WO 2009013405A8 FR 2008000858 W FR2008000858 W FR 2008000858W WO 2009013405 A8 WO2009013405 A8 WO 2009013405A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- spata
- human male
- male fertility
- fertility control
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to human male fertility control. The inventors demonstrates that SPATA 16 is necessary for the formation of the human sperm acrosome and, for this purpose, provide human male contraception means and means for the diagnosis and prognosis of teratospermia and, in particular, a globozoospermia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0704719A FR2918075A1 (en) | 2007-06-29 | 2007-06-29 | CONTROL OF THE FERTILITY OF A HUMAN SEX OF MALE SEX VIA SPATA16 |
FR0704719 | 2007-06-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2009013405A2 WO2009013405A2 (en) | 2009-01-29 |
WO2009013405A8 true WO2009013405A8 (en) | 2009-03-19 |
WO2009013405A3 WO2009013405A3 (en) | 2009-05-14 |
Family
ID=38968877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2008/000858 WO2009013405A2 (en) | 2007-06-29 | 2008-06-19 | Human male fertility control using spata 16 |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2918075A1 (en) |
WO (1) | WO2009013405A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105812358A (en) | 2009-11-10 | 2016-07-27 | 交互数字专利控股公司 | Collaborative session control transfer and inter-device transfer in internet protocol multimedia subsystem |
FR2952373B1 (en) | 2009-11-12 | 2013-05-17 | Univ Grenoble 1 | CONTROL OF HUMAN FERTILITY VIA DPY19L2 |
TW201605213A (en) | 2010-03-04 | 2016-02-01 | 內數位專利控股公司 | Method and apparatus for identification and transfer in internet protocol multimedia subsystem collaborative sessions |
CN102812686B (en) | 2010-03-18 | 2017-05-24 | 交互数字专利控股公司 | Authorizing inter user element session transfer |
CN105085675A (en) * | 2014-05-14 | 2015-11-25 | 深圳市第二人民医院 | Mouse SPATA16 gene polyclonal antibody and preparation method thereof |
JP2023528090A (en) * | 2020-06-01 | 2023-07-03 | コロナ フィード アディティブス エル.エル.シー. | Porcine contraceptive compositions, systems and methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2449909A1 (en) * | 2001-06-19 | 2002-12-27 | The Population Council, Inc. | Male contraceptives |
CN1869222A (en) * | 2005-05-24 | 2006-11-29 | 中国医学科学院基础医学研究所 | Rat testis high expression gene rDJL taking part in spermatozoon acrosome formation |
-
2007
- 2007-06-29 FR FR0704719A patent/FR2918075A1/en active Pending
-
2008
- 2008-06-19 WO PCT/FR2008/000858 patent/WO2009013405A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009013405A3 (en) | 2009-05-14 |
FR2918075A1 (en) | 2009-01-02 |
WO2009013405A2 (en) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009013405A8 (en) | Human male fertility control using spata 16 | |
WO2009021754A3 (en) | Monospecific and multispecific antibodies and method of use | |
WO2007124317A3 (en) | Anchoring system for prosthetic orthotic devices | |
WO2009049161A3 (en) | Reconstruction device | |
MX2009004616A (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens. | |
WO2008025015A3 (en) | Epitope-protein scaffolds and their use | |
WO2007100617A3 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
WO2008089087A3 (en) | Tablet-in-tablet compositions | |
WO2007093627A3 (en) | Biocidal composition | |
WO2007128802A3 (en) | Use of flibanserin for the treatment of post-menopausal sexual desire disorders | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
WO2009089260A3 (en) | Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases | |
WO2010132882A8 (en) | Sublingual dexmedetomidine compositions and methods of use thereof | |
WO2008066784A3 (en) | Expression of foxp3 by cancer cells | |
MX2007005587A (en) | Novel composition for easing human child birth. | |
WO2006127152A3 (en) | Methods for making and using regulatory t cells | |
WO2010130785A3 (en) | Novel use of probiotics | |
WO2006042021A3 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
WO2007097833A3 (en) | Text box numbering and linking visual aids | |
EP2069377A4 (en) | Methods and compositions for the treatment of skin diseases and disorders | |
WO2008035066A3 (en) | Processes for the preparation of ciclesonide and its crystal form | |
WO2008083130A3 (en) | Amorphous and crystalline form a of carvedilol phosphate | |
WO2007144057A3 (en) | Antimicrobial carbon | |
WO2007141530A3 (en) | Treatment of excess sebum production | |
WO2008089488A3 (en) | Biodegradable intravaginal devices for delivery of therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08826552 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08826552 Country of ref document: EP Kind code of ref document: A2 |